Jérôme Desrame
Impact in
Papers in
- Co-authors
- Dominique Béchade (44 shared papers)Christophe Louvet (10 shared papers)Thierry André (10 shared papers)Thomas APARICIO (9 shared papers)David Tougeron (7 shared papers)Julien Taı̈eb (15 shared papers)Christophe Tournigand (5 shared papers)Pascal Artru (11 shared papers)
- Journals
- Annals of Oncology (13 papers)Journal of Clinical Oncology (5 papers)Digestive and Liver Disease (4 papers)European Journal of Cancer (2 papers)The Lancet Oncology (2 papers)
- Partner nations
- FranceItalySwitzerland
In The Last Decade
Jérôme Desrame
108 papers receiving 2.6k citations
Jérôme Desrame's Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 1.3k
- Surgery 920
- Gastroenterology 106
- Pulmonary and Respiratory Medicine 571
- Cancer Research 260
Countries citing papers authored by Jérôme Desrame
This map shows the geographic impact of Jérôme Desrame's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Desrame with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Desrame more than expected).
Fields of papers citing papers by Jérôme Desrame
This network shows the impact of papers produced by Jérôme Desrame. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Desrame. The network helps show where Jérôme Desrame may publish in the future.
Co-authors
The 25 scholars most cited alongside Jérôme Desrame, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6) Hit paper breakdown → | 2016 | 349 |
| 2 | Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability–High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study Hit paper breakdown → | 2022 | 292 |
| 3 | 2018 | 126 | |
| 4 | 2020 | 126 | |
| 5 | 2018 | 106 | |
| 6 | 2015 | 103 | |
| 7 | 2021 | 101 | |
| 8 | 2021 | 87 | |
| 9 | 2003 | 78 | |
| 10 | 1999 | 66 | |
| 11 | 2011 | 65 | |
| 12 | 2019 | 60 | |
| 13 | 2004 | 59 | |
| 14 | 2019 | 57 | |
| 15 | 1998 | 53 | |
| 16 | 2019 | 53 | |
| 17 | 2021 | 52 | |
| 18 | 2006 | 45 | |
| 19 | 2019 | 43 | |
| 20 | 2018 | 41 |
About Jérôme Desrame
Jérôme Desrame is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Gastroenterology and Pathology and Forensic Medicine, having authored 119 papers that have together received 2.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (16 papers), Pancreatic and Hepatic Oncology Research (13 papers), Gastric Cancer Management and Outcomes (11 papers), Colorectal and Anal Carcinomas (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Genetic factors in colorectal cancer (7 papers), Gastrointestinal disorders and treatments (6 papers) and Cancer Treatment and Pharmacology (6 papers). The work is most often cited by research in Oncology (1.3k citations), Surgery (920 citations), Gastroenterology (106 citations), Pulmonary and Respiratory Medicine (571 citations) and Cancer Research (260 citations). Jérôme Desrame has collaborated with scholars based in France, Italy and Switzerland. Frequent co-authors include Dominique Béchade, Christophe Louvet, Thierry André, Thomas APARICIO, David Tougeron, Julien Taı̈eb, Christophe Tournigand, Pascal Artru, C Duvic and Astrid Lièvre. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Digestive and Liver Disease, European Journal of Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.